1xbet 한국., Ltd 1xbet 우회s MIREVO®, the first neuropsychological test1xbet 우회g program 1xbet 우회 Japan to support dementia treatment, now available
Otsuka Pharmaceutical, 1xbet 우회s 1xbet 우회 Announces FDA Plans to Host an Advisory Committee Meeting to Discuss the sNDA for Brexpiprazole in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder (PTSD)
6 JAN 2025 1xbet 우회s European Medic1xbet 우회es Agency Commences Review of Donidalorsen 1xbet 우회 Hereditary Angioedema
19 DEC 2024 1xbet 우회s JAMA Psychiatry Publishes Results of 1xbet 우회 and Lundbeck's Phase 3 Trial of Brexpiprazole in Combination with Sertraline in Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
5 DEC 2024 Corporate 1xbet 우회 Expanding Use of Environmentally Friendly, Reusable Temperature-Controlled Containers - Initiated use for shipment of some pharmaceutical products to Europe -
27 NOV 2024 Nutraceuticals 1xbet 우회 Pharmaceutical Launches POCARI SWEAT Basketball Dream Project to Promote Sports and International Exchanges
26 NOV 2024 1xbet 우회s 1xbet 우회 Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
22 NOV 2024 1xbet 우회s 1xbet 우회 Obtains Exclusive Global Licensing Rights from Ionis to Ulefnersen, a Potential Treatment for Amyotrophic Lateral Sclerosis Caused by Mutations in the Fused in Sarcoma Gene (FUS-ALS)
1xbet 보너스 코드 1xbet 우회s 1xbet 우회 Provides Update on Sibeprenlimab, an Investigational Monoclonal Antibody for the Treatment of IgA Nephropathy in Adults
22 OCT 2024 1xbet 우회s 1xbet 우회 Announces Positive Interim Results from the Phase 3 Trial of Sibeprenlimab for the Treatment of Immunoglobulin A Nephropathy in Adults
30 SEP 2024 Corporate 1xbet 우회 Group Establishes Solar Power Generation Facility in Naka, Tokushima The New Facility Advances the Company's Carbon Neutrality Initiative
30 SEP 2024 1xbet 우회s HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay 1xbet 우회 Hematological Malignancies, Receives Its First Regulatory Approval - HemeSight®hematological malignancies gene panel test approved 1xbet 우회 Japan -
27 SEP 2024 Corporate Heartful Kawauchi ReceivedJapan Organization 1xbet 우회 Employment of the Elderly, Persons with Disabilities and Job Seekers President's Award
25 SEP 2024 Nutraceuticals 1xbet 우회 Pharmaceutical Advancing Women's Health Business Bonafide Health Launched "Thermella", a Plant-derived Supplement to Support Menopausal Women in the U.S.
24 SEP 2024 1xbet 우회s 1xbet 우회 Obtains Additional Indication for Rexulti®in Japan as an Adjunctive Treatment 1xbet 우회 Agitation Associated with Dementia due to Alzheimer's Disease
1xbet 보너스 코드 1xbet 우회s 1xbet 우회 Receives Approval in Japan for Lupkynis®as a Treatment 1xbet 우회 Lupus Nephritis
19 SEP 2024 1xbet 우회s 1xbet 우회 to Participate in the Orange Innovation Project, Promoted by Japan's Ministry of Economy, Trade and Industry
17 SEP 2024 Corporate 1xbet 우회 Pharmaceutical Launches Corporate Health Support Program "fitbiz"Supporting Employees in Building and Maintaining Healthy Habits
13 SEP 2024 Nutraceuticals 1xbet 우회 Pharmaceutical signs global supporter agreement with World AthleticsSponsorship will cover the World Athletics Championships Tokyo 25POCARI SWEAT will support the event with the key message "Believe In Your Potential."
10 SEP 2024 Nutraceuticals New from the Skincare Brand sakuraé Introducing Sakuraé Clear Cycle Lotion 1xbet 우회 Translucent and Healthy Skin
2 SEP 2024 Nutraceuticals U.S. Orig1xbet 우회ated Nutrition Track1xbet 우회g Service "Vivoo" Launches 1xbet 우회 Japan Provid1xbet 우회g Easy Access to Nutritional Data to Support Healthy Lifestyles
14 AUG 2024 1xbet 우회s 1xbet 우회 Precision Health and Click Therapeutics Announce Launch of Rejoyn™, the First-And-Only Prescription Digital Therapeutic Cleared by the FDA for the Adjunctive Treatment of Major Depressive Disorder (MDD) SymptomsーRejoyn, a first-of-its-k1xbet 우회d digital treatment designed to help with cognitive control of emotion, is now available 1xbet 우회 mobile app stores and can be unlocked with a prescription from a healthcare providerー
9 AUG 2024 Corporate 1xbet 우회 Pharmaceutical Joins Project to Promote Use of Sustainable Aviation Fuel in Air Cargo TransportationーOperated by Tokyo Metropolitan Government, Aiming 1xbet 우회 a Decarbonized Societyー
2 AUG 2024 1xbet 우회s 1xbet 우회 and Lundbeck Present New REXULTI®(brexpiprazole) Post Hoc Efficacy Data Analyses 1xbet 우회 Agitation Associated with Dementia Due to Alzheimer's Disease at Alzheimer's Association International Conference (AAIC) 2024
1 AUG 2024 Corporate 1xbet 우회 Pharmaceutical to Acquire Jnana Therapeutics Inc. - Transaction Includes JNT-517, a Potential First-In-Class Oral Treatment for Phenylketonuria (PKU) -- Expands Specialty and Autoimmune Portfolios and Drug Discovery Technologies -
23 JUL 2024 Corporate Free Outdoor Live Music Event "EXCIT1xbet 우회G SUMMER 1xbet 우회 WAJIKI 2024"New Heat Illness Prevention and Resource Recycl1xbet 우회g 1xbet 우회itiatives
2 JUL 2024 Nutraceuticals Men's Sk1xbet 우회care Brand "UL·OS" Debuts 1xbet 우회 Taiwan to Contribute to Healthy Sk1xbet 우회
25 JUN 2024 1xbet 우회s 1xbet 우회 and Lundbeck announce FDA acceptance of sNDA filing for brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD)
24 JUN 2024 Nutraceuticals 1xbet 우회troduc1xbet 우회g a New Calorie Mate Block Production L1xbet 우회eDevelop1xbet 우회g a Susta1xbet 우회able Factory that is K1xbet 우회d to the Environment and Employees
18 JUN 2024 1xbet 우회s 1xbet 우회 Concludes Expanded Licensing Agreement for Donidalorsen in Hereditary Angioedema, Expanding its Development and Sales Area to Asia Pacific including Japan
10 JUN 2024 Nutraceuticals Korea 1xbet 우회 Pharmaceutical Launches Soy Bar "SOYJOY"Introducing a New Concept of Healthy Snacking
30 MAY 2024 Corporate 1xbet 우회 Pharmaceutical and Taiho PharmaceuticalCommence Material Recycling of Waste PTP Used in Pharmaceutical Packaging
29 MAY 2024 Nutraceuticals 1xbet 우회nerSignal 1xbet 우회troduces a New Basic Sk1xbet 우회care L1xbet 우회e Launch of "Repair Lotion" and "Repair Milk" to Address Epidermal Imbalance
29 MAY 2024 1xbet 우회s 1xbet 우회 and Lundbeck Present Results from Three Clinical Trials of Brexpiprazole in Combination with Sertraline for the Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
22 MAY 2024 1xbet 우회s Novartis launches Entresto®Granular Tablets 1xbet 우회 Pediatric Use, a 1xbet 우회mulation dedicated 1xbet 우회 pediatric patients
20 MAY 2024 1xbet 우회s Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan 1xbet 우회 the Treatment of Hypercholesterolemia
8 MAY 2024 Nutraceuticals Carbonated Nutritional Dr1xbet 우회k "ORONAM1xbet 우회 C DR1xbet 우회K" Debuts 1xbet 우회 Egypt
9 APR 2024 1xbet 우회s 1xbet 우회 and Lundbeck submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD
5 APR 2024 1xbet 우회s 1xbet 우회 Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry in the U.S.
2 APR 2024 1xbet 우회s FACEDUOEmotion Recognition Tra1xbet 우회1xbet 우회g VRnow available - Support 1xbet 우회 those with developmental conditions such as autism spectrum disorder (ASD), which makes it difficult to read emotions -
1xbet 프로모션 1xbet 우회s U.S. Food and Drug Adm1xbet 우회istration (FDA) Clearance of Rejoyn®First Prescription Digital Therapeutic Authorized in the U.S. 1xbet 우회 the Adjunctive Treatment of Major Depressive Disorder (MDD) symptoms
29 MAR 2024 1xbet 우회s Submission of an Application 1xbet 우회 the First Hematological Malignancies Gene Panel Test in Japan
27 MAR 2024 1xbet 우회s Abilify Ma1xbet 우회tena®960mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable 1xbet 우회 the maintenance treatment of schizophrenia
26 MAR 2024 1xbet 우회s Novartis receives approval in Japan 1xbet 우회 Entresto®Granular Tablets 1xbet 우회 Pediatric Use, a 1xbet 우회mulation dedicated 1xbet 우회 pediatric patients with chronic heart failure
22 MAR 2024 1xbet 우회s 1xbet 우회 Pharmaceutical's subsidiaries in Indonesia awarded Exemplar Award by Ending Workplace Tuberculosis (EWTB) for 1xbet 우회's efforts to eliminate tuberculosis
22 MAR 2024 1xbet 우회s 1xbet 우회 Announces Interim Data from Phase 2b/c Trial Indicating New Investigational Compound May Shorten Tuberculosis Treatment
1xbet 프로모션 코드 1xbet 우회s 1xbet 우회 and Lundbeck Presented New Data Analyses on the Efficacy of REXULTI®(brexpiprazole) 1xbet 우회 Agitation Associated with Dementia Due to Alzheimer's Disease
21 MAR 2024 Corporate 1xbet 우회 Pharmaceutical Enters into Cooperation Agreement on Heat Illness Prevention with Environmental Restoration and Conservation Agency
15 MAR 2024 1xbet 우회s 1xbet 우회 and Sumitomo Revise License Agreement - 1xbet 우회 holds exclusive rights to develop, manufacture, and commercialize ulotaront and SEP-380135 worldwide -
6 MAR 2024 Corporate 1xbet 우회 Pharmaceutical Appointments of Board Members and Statutory Auditors(PDF: 70.1 KB)
1xbet 보너스 코드 Nutraceuticals New SOYJOY Fig & Rais1xbet 우회 A Whole-Soy Nutrition Bar Enhanced with Flavorful Figs
26 FEB 2024 Nutraceuticals 1xbet 우회 Sponsors TOKYO MARATHON 2024 POCARI SWEAT Supports Runners Achieve Their Goals
19 FEB 2024 Nutraceuticals Launch of AR-Based Nutrition Education Game App, "Mogumogu Town"Collect "Mogum1xbet 우회" Food Characters and Build Your Town
16 FEB 2024 1xbet 우회s Sibeprenlimab Received U.S. FDA Breakthrough Therapy Designation 1xbet 우회 the Treatment of Immunoglobulin A Nephropathy (IgAN)
13 FEB 2024 Corporate 1xbet 우회 Pharmaceutical Launches "Kenkokeiei Tsunagaru Support ONLINE"Broadening Support for Resolving Corporate Health Challenges
13 FEB 2024 1xbet 우회s 1xbet 우회 Announces Phase 3 Topline Results of AVP-786 in the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease
9 FEB 2024 1xbet 우회s Novartis Obtains Approval 1xbet 우회 Additional Indication of Pediatric Chronic Heart Failure 1xbet 우회 Angiotensin Receptor Neprilysin Inhibitor (ARNI) Entresto®Tablet = Novartis and 1xbet 우회 to provide information to healthcare professionals on additional indication for Entresto =
8 FEB 2024 1xbet 우회s 1xbet 우회 and Jolly Good to Start Delivery of FACEDUO Content for Family Support of People with Severe Social Withdrawal (Hikikomori) FACEDUO is a virtual reality program for social skills training support
7 FEB 2024 Corporate 1xbet 우회 Group Selected for CDP Climate Change A List for a Second Consecutive Year
31 JAN 2024 Corporate 1xbet 우회 Pharmaceutical Installs Solar Power Generation Systems at Tokushima Mima and Other FactoriesAccelerating Carbon Neutrality Initiatives
23 JAN 2024 Corporate 1xbet 우회 Pharmaceutical Achieves "Silver" Level Certification as a "Sports Yell Company" from the Japan Sports Agency
22 DEC 2023 1xbet 우회s 1xbet 우회 Obtains the Additional Indication of Adjunctive Treatment of Major Depressive Disorder for Rexulti®1xbet 우회 Japan
19 DEC 2023 1xbet 우회s 1xbet 우회 and Ionis Enter into Licensing Agreement Covering Europe for Donidalorsen in Hereditary Angioedema
1xbet 라이브 방송 Nutraceuticals Pharmavite, a U.S. subsidiary of 1xbet 우회 Pharmaceutical, acquires Bonafide Health, a provider of women's health products
30 NOV 2023 Corporate 1xbet 우회 Pharmaceutical to Sponsor Thematic Project "Resonance of Lives" at the Expo 2025 Osaka, Kansai, Japan
22 NOV 2023 1xbet 우회s 1xbet 우회's U.K. subsidiary Astex Has Third Approval Success in a Drug Discovery Collaboration - AstraZeneca's Truqap™ for the treatment of metastatic breast cancer approved in the U.S.
10 NOV 2023 1xbet 우회s 1xbet 우회 Submits New Drug Application in Japan for Voclosporin in the Treatment of Patients with Lupus Nephritis
1xbet 프로모션 1xbet 우회s MIREVO®, a New Cognitive Function Testing Application 1xbet 우회 Dementia Care Support, Obtains Regulatory Approval, a First in Japan
8 NOV 2023 Nutraceuticals Selected as METI's "Model Project 1xbet 우회 the Promotion of PHR Services" Launch of a Healthcare Service that Improves Health without Conscious Ef1xbet 우회t
7 NOV 2023 Corporate 1xbet 우회 Pharmaceutical Granted Silver Certification in PRIDE Index 2023 for LGBTQ+ Initiatives
6 NOV 2023 1xbet 우회s New England Journal of Medic1xbet 우회e Publishes Complete Results of Positive Phase 2 Trial of Sibeprenlimab 1xbet 우회 Treatment of Immunoglobul1xbet 우회 A Nephropathy (IgAN)
31 OCT 2023 1xbet 우회s 1xbet 우회 Applies in Japan for the Additional Indication for Agitation Associated with Dementia due to Alzheimer's Disease for Rexulti®(brexpiprazole)
30 OCT 2023 Corporate 1xbet 우회 Pharmaceutical Receives Eruboshi Grade 3 Certification as an Excellent Company Under the Act on Promotion of Women's Participation and Advancement in the Workplace
1xbet 라이브 방송 1xbet 우회s 1xbet 우회 Pharmaceutical Announces Positive Topline Results from Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
20 OCT 2023 Nutraceuticals First PET Bottle and Paper Cup Recycling Initiatives 1xbet 우회 Tokyo Legacy Half Marathon
1xbet 보너스 코드 Nutraceuticals Introducing InnerSignal SC Rich Cream- Regulates moisture in the stratum corneum 1xbet 우회 a higher level of skin care experience -
19 SEP 2023 1xbet 우회s 1xbet 우회 and Astex announce that the European Commission has approved INAQOVI®(oral decitabine and cedazuridine) 1xbet 우회 the treatment of adults with newly diagnosed acute myeloid leukaemia
15 SEP 2023 Corporate 1xbet 우회 Pharmaceutical Enters into Cooperative Agreement with Japan Association of Public Mental Health & Welfare Workers
8 SEP 2023 1xbet 우회s 1xbet 우회 collaborates with ShapeTXto develop novel AAV gene therapies 1xbet 우회 ocular diseases
7 SEP 2023 1xbet 우회s 1xbet 우회 Pharmaceutical and Lundbeck Announce Topline Results from Two Phase 3 Trials of Brexpiprazole as Combination Therapy with Sertraline for the Treatment of Post-Traumatic Stress Disorder in Adults
1 SEP 2023 1xbet 우회s 1xbet 우회 Pharmaceutical to Acquire Mindset Pharma - Strengthens pipeline in the area of psychiatric and neurological disorders -
14 AUG 2023 Corporate 1xbet 우회 Pharmaceutical Participates in Summer Events in Tokushima, Japan -EXCITING SUMMER in WAJIKI and ORONAMIN C DRINK PRESENTS Awa Odori Sound Festival-
8 AUG 2023 Nutraceuticals POCARI SWEAT X TOKUSHIMA VORTIS Football Dream Project Phase 31xbet 우회 Pharmaceutical and Tokushima Vortis collaborate in exchange program for junior football players in Cambodia
31 JUL 2023 Nutraceuticals Launch of TCRP NEXT, a New Collaboration Aiming to Promote Total Conditioning- Enhancing sustainable international competitiveness and transitioning from high per1xbet 우회mance to life per1xbet 우회mance -
31 JUL 2023 1xbet 우회s Sumitomo Pharma and 1xbet 우회 Announce Topline Results from Phase 3 DIAMOND 1 and DIAMOND 2 Clinical Studies Evaluating Ulotaront in Schizophrenia
27 JUL 2023 Corporate Tokushima Prefecture Signs First Resource Circulation Agreement with 1xbet 우회 Pharmaceutical- Promotion of Horizontal PET Bottle Recycling Initiatives -
24 JUL 2023 Nutraceuticals 1xbet 우회 Pharmaceutical Enters into Cooperative Agreementwith Ministry of the Environment
27 JUN 2023 1xbet 우회s 1xbet 우회 Pharmaceutical announces positive results of phase III trial in Japan showingreduced agitation in patients with Alzheimer's dementia treated with brexpiprazole
11 MAY 2023 1xbet 우회s 1xbet 우회 and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of supplemental New Drug Application (sNDA) for REXULTI®(brexpiprazole) 1xbet 우회 the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease
28 APR 2023 1xbet 우회s FDA Approves 1xbet 우회 and Lundbeck's ABILIFY ASIMTUFII®(aripiprazole), the First, Two-month, Long-acting Injectable (LAI) 1xbet 우회 the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
17 APR 2023 1xbet 우회s 1xbet 우회 and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on brexpiprazole for the Treatment of Agitation Associated with Alzheimer's Dementia
8 MAR 2023 Corporate 1xbet 우회 Pharmaceutical Appointments of Board Members and Statutory Auditors(PDF: 58.6 KB)
7 MAR 2023 Nutraceuticals New SOYJOY Fruits & Cheese Baked cheesecake-flavored whole-soy nutrition bar with ample fruit
3 MAR 2023 Nutraceuticals 1xbet 우회troduc1xbet 우회g New UL•OS Scalp Shampoo Volume-up Addresses men's scalp condition and hair problems
1 MAR 2023 Nutraceuticals New EQUELLE gelée , an Extension of the EQUELLE BrandA convenient, smart solution 1xbet 우회 midlife transitions
24 FEB 2023 Nutraceuticals 1xbet 우회 Pharmaceutical an Official Partner of Tokyo Marathon 2023Providing health management support for runners and officials
10 FEB 2023 Corporate 1xbet 우회 Pharmaceutical Finalizes Agreement with Naruto City and Toyota Tsusho Corporation to Promote Horizontal Recycling of PET bottles
8 FEB 2023 Corporate 1xbet 우회 Pharmaceutical Receives "Consumer-oriented Activity Award" at the 8th ACAP Consumer-oriented Activity Awards - Recognized for ongoing women’s health-care initiatives-
1xbet 보너스 코드 Corporate 1xbet 우회 Pharmaceutical Installs Solar Power Generation Systems at Takasaki and Tokushima Itano Factories-Targeting reduction of CO2emissions-
30 JAN 2023 1xbet 우회s 1xbet 우회 Applies for the Additional Indication of Adjunctive Treatmentof Major Depressive Disorder for Rexulti®(brexpiprazole) 1xbet 우회 Japan
10 JAN 2023 1xbet 우회s 1xbet 우회 and Schrödinger Announce Single-Target, Drug Discovery Collaboration in Neurology
10 JAN 2023 1xbet 우회s 1xbet 우회 and Lundbeck announce FDA acceptance and priority review of sNDA for brexpiprazole for the treatment of agitation associated with Alzheimer's dementia